Sandbox:MDS: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 38: | Line 38: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | ||
|valign=top| | |valign=top| | ||
|+ | |+ | ||
Line 47: | Line 47: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align=center | | ||
Refractory cytopenia with unilineage dysplasia | Refractory cytopenia with unilineage dysplasia | ||
Line 63: | Line 63: | ||
Refractory anemias with excess blasts I and II | Refractory anemias with excess blasts I and II | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts in transformation]] I–IV ''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts in transformation]] I–IV ''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align=center | | ||
5q - syndrome | 5q - syndrome | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Chronic myelomonocytic leukemia]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Chronic myelomonocytic leukemia]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align=center | | ||
Myelodysplastic-myeloproliferative overlap syndromes | Myelodysplastic-myeloproliferative overlap syndromes |
Latest revision as of 15:06, 8 December 2015
Name | Description |
---|---|
Refractory anemia |
|
Refractory anemia with ring sideroblasts (RARS)| |
|
Refractory anemia with excess blasts (RAEB) |
|
Refractory anemia with excess blasts in transformation (RAEB-T) |
|
Chronic myelomonocytic leukemia (CMML) |
|
Old system | New system |
---|---|
Refractory anemia |
Refractory cytopenia with unilineage dysplasia |
Refractory anemia with ringed sideroblasts |
Refractory anemia with ring sideroblasts |
Refractory cytopenia with multilineage dysplasia | |
Refractory anemia with excess blasts |
Refractory anemias with excess blasts I and II |
Refractory anemia with excess blasts in transformation I–IV |
5q - syndrome |
Chronic myelomonocytic leukemia |
Myelodysplastic-myeloproliferative overlap syndromes |
Refractory cytopenia of childhood | |
Unclassifiable myelodysplastic syndrome |